Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma
Clinical trial NCT01369888 · TERMINATED
Trial details
- NCT number
- NCT01369888
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.